Abstract
The range and extent of inhaled corticosteroid (ICS) side effects experienced by patients in the general community are likely to be underestimated. Aims: To identify the side effects of ICS perceived by patients in the community and, through the use of a self-report questionnaire, measure their intensity, prevalence and relationship with daily medication dose. Methods: Focus groups and in-depth interviews were conducted to identify side effects that patients associated with their use of ICS. In an international multicentre cross-sectional survey, 395 inhaler users from community pharmacy (mean age 50, 53% female), divided into 4 daily dosage groups (beta(2)-agonist without ICS n = 66, beclometasone dipropionate (BDP) equivalent ICS low dose 800 mu g, n = 69) reported how much they were affected by these side effects on a 7-point Likert scale.
Original language | English |
---|---|
Pages (from-to) | 1318-1336 |
Number of pages | 19 |
Journal | Respiratory Medicine |
Volume | 100 |
Issue number | 8 |
DOIs | |
Publication status | Published - Aug-2006 |
Keywords
- adverse effects
- glucocorticoids
- administration
- inhalation
- administration and dosage
- ADVERSE DRUG-REACTIONS
- ASTHMATIC-PATIENTS
- RISK
- AEROSOL
- COUGH